Morgan Stanley Maintains Zenas BioPharma(ZBIO.US) With Buy Rating, Maintains Target Price $40

Moomoo NewsNov 14 07:31 ET · Ratings

Zenas BioPharma's Promising Pipeline and Strategic Moves Earn Buy Rating

TipRanksNov 14 06:57 ET · Ratings

Zenas BioPharma | 10-Q: Q3 2024 Earnings Report

SECNov 12 13:44 ET · Announcements

Zenas BioPharma Completed Targeted Enrollment of Phase 3 INDIGO Trial

TipRanksNov 12 07:25 ET

Zenas BioPharma 3Q Research and Development Expenses $33.5M >ZBIO

Dow JonesNov 12 07:16 ET

Express News | Zenas Biopharma Inc: Qtrly Net Loss per Share $5.02

ReutersNov 12 07:14 ET